Therefore, this study analyzed chemical components of TX using UPLC-Q-TOF-MS/MS, predicted potential mechanism through transcriptomic analysis, and confirmed its activation of the PI3K-AKT signaling pathway for treating RCC through in vitro cell experiments. The gene discussed is PIK3CG; the disease is renal cell carcinoma.